For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body—a ...

CVS Health announced plans to drop Eli Lilly's Zepbound from its preferred coverage in favor of Novo Nordisk A/S's Wegovy for weight loss — a major blow to the Indianapolis pharmaceutical company.

The fear of not being able to breathe without the spray can cause significant anxiety, making it harder to stop using it even when symptoms worsen. So, what can you use instead? Saline nasal ...

Four state attorneys general sued CVS Health and its pharmacies for allegedly submitting “false and fraudulent” claims to state Medicaid programs. Connecticut, Indiana, Oklahoma and ...

The US Food and Drug Administration (FDA) has approved dihydroergotamine (DHE) nasal powder (Atzumi, Satsuma Pharmaceuticals Inc) for the acute treatment of migraine with or without aura in adults ...

CVS Health plans to exit the individual health insurance business also known as Obamacare next year, leaving about 1 million Aetna members in 17 states looking for new coverage in 2026. The ...

CVS Health (NYSE:CVS) is set to publish its earnings report on Thursday, May 1, 2025. Historically, the stock's response to earnings announcements has been evenly divided. In the last five years ...

But one business in this unincorporated community east of downtown Los Angeles has unwittingly become an unusual local icon, given the sheer weirdness of its existence: the resident CVS Pharmacy.

So please don't do that." Cleveland Clinic experts have highlighted that rhinitis medicamentosa could impact "anyone" who uses nasal decongestant sprays, drops or gels. "It usually affects people ...

CVS Health reported robust year-over-year growth in Q1 2025 earnings, with significant increases in sales, revenue, and net income, though the company adjusted its annual earnings guidance downward.